ArticleSpectrochimica acta. Part A, Molecular and biomolecular spectroscopy2022
Sticking - pulling strategy for assessment of combined medicine for management of tough symptoms in COVID-19 Pandemic using different windows of spectrophotometric Platform-Counterfeit products' detection.
Article in Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 21 citations in OpenAlex.
- Integrating Artificial intelligence within sustainable smart analytical chemistry for analyzing the divisor impact on UV-spectrophotometric efficiency of solifenacin and mirabegron combination.Scientific reports · 2026Article
- Green HPLC strategy for quantification of carvedilol and hydrochlorothiazide in cardiac medications with in-vitro dissolution kinetics and impurity profiling.BMC chemistry · 2025Article
- Smart green spectrophotometric estimation and content uniformity testing of chlorphenoxamine HCl and caffeine in bulk forms and combined pharmaceutical formulation.Scientific reports · 2025Article
- Risk assessment based on spectrophotometric signals used in eco-friendly analytical scenarios for estimation of carvedilol and hydrochlorothiazide in pharmaceutical formulation.Scientific reports · 2024Article
- Article
- Article
- Article
- Article
- Sustainable spectrophotometric determination of antihypertensive medicines reducing COVID-19 risk via paired wavelength data processing technique - Assessment of purity, greenness and whiteness.Sustainable chemistry and pharmacy · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study presents a comprehensive comparative study of different green spectrophotometric approaches without any physical separation on processing a ternary mixture of Aceclofenac (ACE), Paracetamol (PAR) and Rabeprazole (RAB) in combined medicine for managing tough symptoms in the COVID-19 Pandemic. The different univariate complementary resolutions according to the response used for the assay of the cited drugs after applying the processing steps were implemented using successive in-silico sample enrichment for resolving the ternary mixture via different windows of spectrophotometric platform using sticking - pulling strategy (SPS). Window I; based on manipulation of the data of zero order absorption spectrum of the mixture using novel Extended absorbance difference (EAD) and Absorbance difference (AD) methods coupled with corresponding spectrum subtraction method (SS). Window III; based on manipulation of the data of ratio spectra via Constant value coupled with constant subtraction (CV-CS) and novel Induced dual amplitude difference (IDAD) method coupled with corresponding spectrum subtraction method (SS). Finally, window IV; based on manipulation of the data of derivative of the ratio spectrum of the mixture via novel Factorized derivative ratio null contribution (FDD-NC) and Factorized unlimited derivative ratio (FUDD) methods coupled with corresponding spectrum subtraction method (SS). Synthetic mixtures and commercial medicine were constructively analyzed using the proposed methods while maintaining calibration graphs to be linear over ranges; 4.0-40.0 µg/mL for ACE, 2.0-14.0 µg/mL for PAR and 4.0-30.0 µg/mL for RAB. Moreover, methods' validation was confirmed via performing exhaustive statistical treatment of the experimental findings. The proposed methodologies can be used for the routine analysis of the cited drugs in quality control laboratories. Additionally, Spectral Similarity Index (SSI) was calculated to detect counterfeit products and methods' greenness profile was finally guaranteed through analytical greenness (AGREE) metric assessment tool.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.